In contrast, while MIB2 expression shows an opposite trend and is elevated in TNBC relative to ER+ cancers, we did not find differences in the expression of MAPK14 (p38) or MAPKAP2 (MK2) between TCGA ER+ and TNBC samples (Supplementary Fig. 6). The gene discussed is MAPK14; the disease is cancer.